Product review · Updated September 30, 2026
Medik8 Advanced MP care review: current and legacy are separate records
A newer name and peptide count do not provide a transition plan from an older Liquid Peptides product.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
“Liquid Peptides” can refer to more than one manufacturer record. The current US Liquid Peptides Advanced MP page describes 13 peptides, while the older Liquid Peptides page describes a different multi-peptide proposition. A remembered purchase, an older bottle and the newest search result are not automatically interchangeable. That identity problem comes before any interpretation of what a change in product might mean.
This review uses both official records captured on September 30, 2026, plus selected AAD context about existing products and professional assessment. We have not compared physical editions, tested either formula or developed a transition plan. The purpose is to make the version question and the limits of manufacturer advice visible, while retaining the exact current product named in this review.
In this article
Advanced MP is the current product under review
The current US page calls the serum Liquid Peptides Advanced MP and promotes GF MiniProteins alongside 13 peptides for visible wrinkle reduction. Those features identify the current manufacturer record; they do not describe every product that has carried the shorter Liquid Peptides name. Our directory entry is therefore tied to Advanced MP, not to a generic memory of the range.
The consultation product-list guide is an original companion for questions about a named item. Here the distinction is especially consequential: identifying a current website does not establish that a reader’s earlier container belongs to that version, or that the newer formula has already been reviewed within their existing care.
The legacy page has its own identity and claims
The legacy page names Liquid Peptides and advertises a 30 percent multi-peptide complex; its description refers to ten peptides. The retained older product record is separate from the current Advanced MP account. A blend percentage is not a copper measurement, and the difference in advertised peptide counts does not supply a comparison of individual benefit or tolerance.
The current page itself distinguishes the original product from Advanced MP. We preserve that version distinction without adopting its product-choice recommendations. Our Naturium care review offers another reading path concerning published product records. Its facts are independent of the two Medik8 pages being examined here.
Only the current declaration is complete in this capture
The current complete ingredient list names Copper Palmitoyl Heptapeptide-14 along with many other components. It also warns about possible upgrades and regional variants, and identifies packaging as the definitive ingredient list. The current declaration and caveat support the named copper classification while limiting what a website can establish about an individual package.
The retained legacy extract has a full-ingredients heading but does not supply a complete corresponding declaration. That absence prevents a complete ingredient-by-ingredient comparison here. It does not prove the older product lacked an ingredient. The evidence consists of one complete current declaration and a separate, more limited legacy record; we have not silently filled the older gap from the newer page.
Study summaries stay with the version they name
Both pages contain manufacturer study attributions. The legacy record describes a consumer study involving 60 participants over eight weeks, while the current record carries its own outcome claims and qualifiers. We read the legacy summary and current attributions, rather than the full reports behind them. They remain version-specific promotional evidence in this review.
Those summaries do not create a shared trial directly comparing the two products, and they do not establish a reader’s likely result. Our existing-actives conversation guide concerns the outside-care question that such marketing cannot answer. Nothing in these retained summaries establishes a reason, method or schedule for moving from an older product to Advanced MP.
The medical-advice statement has a particular context
In the current FAQ’s pregnancy and nursing discussion, Medik8 says that as a cosmetic brand it cannot provide specific medical advice relating to its products and refers the question to a physician. We keep that statement within its actual FAQ context. It supports a boundary in that answer; it is not evidence that we investigated every brand support policy or clinical circumstance.
We do not offer advice about pregnancy, nursing or eligibility. The relevant observation is that a product page can acknowledge a question beyond its advertised cosmetic scope. Our Drunk Elephant care review is a further editorial reading route, not a professional answer to the medical question discussed in this FAQ.
Existing care is more than a new product description
AAD’s exfoliation guidance explains that existing medicines and skincare products can affect sensitivity in that setting. We use the selected guidance only to establish that current care is relevant context. It is not a copper-peptide compatibility study, and it does not prescribe a Medik8 combination or a transition between the legacy and current formulas.
The current product’s sensitive-skin language remains a manufacturer claim. No personal assessment accompanies it in our record. An older instruction from an appropriate professional, the exact product edition and a newly reported concern are therefore separate issues. This review cannot resolve them through the current peptide count or turn a broad cosmetic description into clearance for an individual reader.
A useful version question does not imply a switch
The evidence supports a current US Advanced MP serum, a separate legacy Liquid Peptides identity and a packaging caveat affecting current online information. The current page helps define the product question; the legacy page preserves what the earlier record actually says. Neither proves what a reader owns or what role either version has in their care.
Our simple-routine comparison provides further site navigation. The conclusion here remains documentary: preserve the correct version and the limits of the available declaration before interpreting a change. A switch, continued use or personal compatibility finding would require conclusions that this review has neither made nor verified.
Sources behind this reading
- Liquid Peptides Advanced MP Face Serum | Medik8 US ↗Official manufacturer product record · Checked September 30, 2026
- Original Liquid Peptides | Medik8 US ↗Official manufacturer product record · Checked September 30, 2026
- How to safely exfoliate at home ↗Medical society patient guidance: selected assessment and safety context · Checked September 30, 2026